"Arrr! FDA be givin’ the green light to Lazertinib and Amivantamab for the lung beasties! Avast, ye scallywags!"
2024-08-20
Arrr, matey! The crew be givin’ the green light to this treasure map of a combo for those scallywags with the nasty lung beast, be it locally advanced or spreadin' far and wide, sportin’ the sly EGFR mutations! Yo ho! <i>Medscape Medical News</i> be shoutin' it loud!
Ahoy there, me hearties! Gather 'round, fer I’ve got news hotter than a cannonball in a thunderstorm! The fine lads and lasses in the realm of medicine be celebratin' a grand approval—aye, that’s right! They’ve set sail with a new combination treatment fer them scallywags sufferin’ from locally advanced or metastatic NSCLC, which be a fancy term fer lung troubles. Only those cursed with the EGFR exon 19 deletions or that pesky exon 21 L858R mutation shall reap the bounty of this fine concoction!